Should You Buy Bristol-Myers Squibb Company (NYSE:BMY) Before Its Ex-Dividend?

98

Bristol-Myers Squibb Company (NYSE:BMY) will begin trading ex-dividend on July 2, 2020. The quarterly dividend payment of $ 0.45 per share is scheduled to be paid on August 3, 2020. To secure the dividend payout, investors must buy the stock prior to the ex-dividend date, latest at the end of the trading session on July 2, 2020.

Dividends History
wpDataTable with provided ID not found!
Stock Performance

According to the previous trading day, closing price of BMY was $ 59.43, representing a 39.90 % increase from the 52 week low of $ 42.48 and a 13.04 % decrease over the 52 week high of $ 68.34.

[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”BMY” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]

The company has a market capital of $ 134.47 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The companys products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.